tiprankstipranks
Advertisement
Advertisement
Lyell Immunopharma initiated with a Buy at B. Riley
PremiumThe FlyLyell Immunopharma initiated with a Buy at B. Riley
1M ago
Lyell Immunopharma files to sell 1.1M shares of common stock for holders
Premium
The Fly
Lyell Immunopharma files to sell 1.1M shares of common stock for holders
1M ago
Citizens healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens healthcare analysts hold an analyst/industry conference call
2M ago
Lyell Gains Buy Rating on Leadership in CD19/20 CAR-T and Ronde-cel Progress; Analyst Reiterates $45 Price Target
PremiumRatingsLyell Gains Buy Rating on Leadership in CD19/20 CAR-T and Ronde-cel Progress; Analyst Reiterates $45 Price Target
4M ago
Lyell Immunopharma initiated with an Outperform at Baird on ronde-cel potential
Premium
The Fly
Lyell Immunopharma initiated with an Outperform at Baird on ronde-cel potential
4M ago
Lyell Immunopharma initiated with an Outperform at Baird
Premium
The Fly
Lyell Immunopharma initiated with an Outperform at Baird
4M ago
Lyell Immunopharma initiated with a Buy at Needham
PremiumThe FlyLyell Immunopharma initiated with a Buy at Needham
4M ago
Lyell Immunopharma: Differentiated Dual‑Target CAR‑T Pipeline and Upcoming Clinical Milestones Support Buy Rating and Acquisition Potential
Premium
Ratings
Lyell Immunopharma: Differentiated Dual‑Target CAR‑T Pipeline and Upcoming Clinical Milestones Support Buy Rating and Acquisition Potential
5M ago
Lyell Immunopharma price target raised to $39 from $32 at Lucid Capital
Premium
The Fly
Lyell Immunopharma price target raised to $39 from $32 at Lucid Capital
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100